Frequency of Ventilator Associated Pneumonia (VAP) in Mechanically Ventilated Patients Using the AnapnoGuard System
Not Applicable
Completed
- Conditions
- Ventilator Associated Pneumonia
- Registration Number
- NCT01126320
- Lead Sponsor
- Hospitech Respiration
- Brief Summary
Ventilator Associated Pneumonia (VAP) is a common complication experienced by mechanically ventilated patients and within the framework of Respiratory Intensive Care Units. The AnapnoGuard system, developed by Hospitech Respiration Ltd. is a ventilation guard system that includes a number of unique characteristics. This study was designed to test the frequency VAP in mechanically ventilated ICU patients using the AnapnoGuard System.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 161
Inclusion Criteria
- ICU patients;
- Patient was connected to AnapnoGuard system up to six hours from intubation;
- Age - above 18.
Exclusion Criteria
- Pneumonia;
- Aspiration Pneumonia;
- Chronic or Severe Pneumonia;
- Chronic Obstructive Pulmonary Disease (COPD) requiring permanent home-based antibiotic treatment;
- Interstitial Lung Disease (ILD);
- Post Lung Transplant State;
- Immunosuppression.
- Patients ventilated in prone position
- Patient who was ventilated 3 months prior to being enrolled in the study
- Pregnant women
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method VAP occurence 2 years
- Secondary Outcome Measures
Name Time Method Adverse events occurence 2 years
Trial Locations
- Locations (1)
RAMBAM Medical Center
🇮🇱Haifa, Israel
RAMBAM Medical Center🇮🇱Haifa, Israel